# Omega Healthcare Investors Inc. (OHI) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $46.38, market value $14.8 billion.

## Valuation
- **P/E (trailing): 16.5×** (5-yr avg 18.7×, 3-yr avg 23.3×). Omega Healthcare Investors Inc. trades at 16.5× trailing earnings, close to its own five-year average of 18.7×. The Real Estate median in the September 2026 study was 25.2×. Forward P/E is 22.9×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 0.91**. A PEG of 0.91 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 22.7×**. Each dollar of revenue is priced at 22.7×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 2.6×**. The shares trade at 2.6× book value; book value is a meaningful part of the valuation.
- **Earnings yield: 6.1%**. The inverse of the P/E: 6.1% of the price is earned each year.

## Profitability
- **Net margin: 49.6%**. 49.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 11.4%**. 11.4% on shareholders' equity is solid.
- **Return on assets: 8.5%**. Each dollar of assets produces 8.5% of profit.

## Growth
- **Revenue growth (1 yr): 13.2%** (3-yr 10.7%/yr, 5-yr 5.9%/yr). Revenue grew 13.2% over the last year, against 5.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 25.2%** (3-yr 2.5%/yr, 5-yr 22.6%/yr). Earnings per share rose 25.2%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.82**. Debt is 0.82 times equity, moderate leverage.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 5.86%** ($2.69 per share, trailing). Omega Healthcare Investors Inc. yields 5.86%, an income-level yield.
- **Payout ratio: 132%**. The dividend exceeds earnings (132% payout), which is rarely sustainable outside REITs and one-off years.
- **Consecutive years of increases: 23**. 23 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 0.0%/yr** (1-yr 0.0%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: buy** (18 analysts). 18 analysts cover Omega Healthcare Investors Inc.; the consensus is buy, with an average price target of $51.89 (+12% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 13.6%** (YTD 7.7%, 3-mo 4.3%). The shares are up 13.6% over twelve months including dividends.
- **From 52-week high: -11.5%** (18.1% above the low). Trading 11% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): -0.25** (volatility 21%). Beta of -0.25 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=OHI · Page: https://foliofundamentals.com/stocks/ohi

Not investment advice.